{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:38:31Z","timestamp":1788349111981,"version":"build-2803163510"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T00:00:00Z","timestamp":1683849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009360","name":"King\u2019s College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009360","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000764","name":"King's College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000764","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009362","name":"South London and Maudsley NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011705","name":"MQ Transforming Mental Health","doi-asserted-by":"publisher","award":["MQBF\/1"],"award-info":[{"award-number":["MQBF\/1"]}],"id":[{"id":"10.13039\/100011705","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011705","name":"MQ Transforming Mental Health","doi-asserted-by":"publisher","award":["MQBF\/4"],"award-info":[{"award-number":["MQBF\/4"]}],"id":[{"id":"10.13039\/100011705","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/L011794\/1"],"award-info":[{"award-number":["MR\/L011794\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N013700\/1"],"award-info":[{"award-number":["MR\/N013700\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000276","name":"Department of Health and Social Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.bbi.2023.05.005","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T02:17:22Z","timestamp":1683857842000},"page":"343-351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["The association between peripheral inflammation, brain glutamate and antipsychotic response in Schizophrenia: Data from the STRATA collaboration"],"prefix":"10.1016","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0366-3542","authenticated-orcid":false,"given":"Sunniva","family":"Fenn-Moltu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bill","family":"Deakin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Drake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver D.","family":"Howes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Lawrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sh\u00f4n","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naghmeh","family":"Nikkheslat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T.R.","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"MacCabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Mondelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Egerton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bbi.2023.05.005_b0005","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00127-014-0887-z","article-title":"Inflammatory biomarker profiles of mental disorders and their relation to clinical, social and lifestyle factors","volume":"49","author":"Baumeister","year":"2014","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"issue":"9","key":"10.1016\/j.bbi.2023.05.005_b0010","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00213-015-4044-5","article-title":"Effects of psychotropic drugs on inflammation: Consequence or mediator of therapeutic effects in psychiatric treatment?","volume":"233","author":"Baumeister","year":"2016","journal-title":"Psychopharmacology"},{"issue":"13","key":"10.1016\/j.bbi.2023.05.005_b0015","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1007\/s00213-016-4318-6","article-title":"Targeting glutamate to treat schizophrenia: Lessons from recent clinical studies","volume":"233","author":"Beck","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbi.2023.05.005_b0020","article-title":"The Role of Infections and Autoimmune Diseases for Schizophrenia and Depression: Findings from Large-Scale Epidemiological Studies","volume":"8","author":"Benr\u00f3s","year":"2015","journal-title":"Immunol. Psychiatry"},{"key":"10.1016\/j.bbi.2023.05.005_b0025","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fpsyt.2017.00079","article-title":"Risk-Conferring Glutamatergic Genes and Brain Glutamate Plus Glutamine in Schizophrenia","volume":"8","author":"Bustillo","year":"2017","journal-title":"Front. Psych."},{"issue":"4","key":"10.1016\/j.bbi.2023.05.005_b0030","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2478\/s13380-012-0045-6","article-title":"Prenatal infection, maternal immune activation, and risk for schizophrenia","volume":"3","author":"Canetta","year":"2012","journal-title":"Transl. Neurosci."},{"key":"10.1016\/j.bbi.2023.05.005_b0035","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12888-016-0866-x","article-title":"The value of interleukin 6 as a peripheral diagnostic marker in schizophrenia","volume":"16","author":"Chase","year":"2016","journal-title":"BMC Psychiatry"},{"issue":"8","key":"10.1016\/j.bbi.2023.05.005_b0040","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1038\/s41386-018-0038-4","article-title":"Influence of plasma cytokines on kynurenine and kynurenic acid in schizophrenia","volume":"43","author":"Chiappelli","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.bbi.2023.05.005_b0045","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000148197","article-title":"Increased Serum Levels of Inflammatory Markers in Chronic Institutionalized Patients with Schizophrenia","volume":"15","author":"Coelho","year":"2008","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.bbi.2023.05.005_b0050","doi-asserted-by":"crossref","unstructured":"Cui, G. bin, An, J. ze, Zhang, N., Zhao, M. gao, Liu, S. bing, & Yi, J. (2012). Elevated interleukin-8 enhances prefrontal synaptic transmission in mice with persistent inflammatory pain. Mol. Pain 8. https:\/\/doi.org\/10.1186\/1744-8069-8-11.","DOI":"10.1186\/1744-8069-8-11"},{"issue":"1","key":"10.1016\/j.bbi.2023.05.005_b0055","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.biopsych.2018.06.016","article-title":"Associations Between Non-neurological Autoimmune Disorders and Psychosis: A Meta-analysis","volume":"85","author":"Cullen","year":"2019","journal-title":"Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.bbi.2023.05.005_bib456","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/jamapsychiatry.2013.289","article-title":"Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study","volume":"70","author":"de la Fuente-Sandoval","year":"2013","journal-title":"JAMA psychiatry"},{"key":"10.1016\/j.bbi.2023.05.005_b0060","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbi.2012.06.010","article-title":"Serum and gene expression profile of cytokines in first-episode psychosis","volume":"31","author":"Di Nicola","year":"2013","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"10.1016\/j.bbi.2023.05.005_b0065","doi-asserted-by":"crossref","first-page":"e0121945","DOI":"10.1371\/journal.pone.0121945","article-title":"cocor: A Comprehensive Solution for the Statistical Comparison of Correlations","volume":"10","author":"Diedenhofen","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbi.2023.05.005_b0070","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11064-018-2521-z","article-title":"Magnetic Resonance Spectroscopy in Schizophrenia: Evidence for Glutamatergic Dysfunction and Impaired Energy Metabolism","volume":"44","author":"Duarte","year":"2019","journal-title":"Neurochem. Res."},{"issue":"11","key":"10.1016\/j.bbi.2023.05.005_b0075","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1038\/npp.2012.113","article-title":"Anterior cingulate glutamate levels related to clinical status following treatment in first-episode schizophrenia","volume":"37","author":"Egerton","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"APR","key":"10.1016\/j.bbi.2023.05.005_b0080","first-page":"1","article-title":"Effects of antipsychotic administration on brain glutamate in schizophrenia: A systematic review of longitudinal1H-MRS studies","volume":"8","author":"Egerton","year":"2017","journal-title":"Front. Psychiatry"},{"issue":"11","key":"10.1016\/j.bbi.2023.05.005_b0085","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1038\/s41380-018-0082-9","article-title":"Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: A multicentre 1H-MRS study (OPTiMiSE)","volume":"23","author":"Egerton","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2023.05.005_b0090","doi-asserted-by":"crossref","unstructured":"Egerton, A., Griths, K., Casetta, C., Deakin, J., Drake, R., Howes, O., Kassoumeri, L., Khan, S., Lankshear, S., Lees, J., Lewis, S., Mikulskaya, E., Millgate, E., Oloyede, E., & Pollard, R. (2022). Anterior Cingulate Glutamate Metabolites as a Predictor of Antipsychotic Response in First Episode Psychosis: Data from the STRATA collaboration. https:\/\/doi.org\/10.21203\/RS.3.RS-1753398\/V1.","DOI":"10.21203\/rs.3.rs-1753398\/v1"},{"key":"10.1016\/j.bbi.2023.05.005_b0095","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.schres.2020.09.013","article-title":"Glutamate in schizophrenia: Neurodevelopmental perspectives and drug development","volume":"223","author":"Egerton","year":"2020","journal-title":"Schizophr Res."},{"issue":"2","key":"10.1016\/j.bbi.2023.05.005_b0100","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/schbul\/sbaa128","article-title":"Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA)","volume":"47","author":"Egerton","year":"2021","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2023.05.005_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2020.12.020","article-title":"Peripheral immune markers and antipsychotic non-response in psychosis","volume":"230","author":"Enache","year":"2021","journal-title":"Schizophr. Res."},{"issue":"10","key":"10.1016\/j.bbi.2023.05.005_b0110","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/mp.2015.168","article-title":"Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression","volume":"21","author":"Felger","year":"2016","journal-title":"Mol. Psychiatry"},{"issue":"6","key":"10.1016\/j.bbi.2023.05.005_b0115","first-page":"449","article-title":"Interleukin-6: The missing element of the neurocognitive deterioration in schizophrenia? The focus on genetic underpinnings, cognitive impairment and clinical manifestation","volume":"265","author":"Frydecka","year":"2014","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"5","key":"10.1016\/j.bbi.2023.05.005_b0120","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1471-4159.2009.05872.x","article-title":"IFN-gamma and IL-4 differentially shape metabolic responses and neuroprotective phenotype of astrocytes","volume":"108","author":"Garg","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbi.2023.05.005_b0125","unstructured":"Garnier, Simon, Ross, Noam, Rudis, Robert, Camargo, Pedro, A., Sciaini, Marco, Scherer, & C\u00e9dric. (2021). {viridis}\u2014Colorblind-Friendly Color Maps for R. https:\/\/doi.org\/10.5281\/zenodo.4679424."},{"issue":"6","key":"10.1016\/j.bbi.2023.05.005_b0130","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/mrm.20901","article-title":"Use of tissue water as a concentration reference for proton spectroscopic imaging","volume":"55","author":"Gasparovic","year":"2006","journal-title":"Magn. Reson. Med."},{"issue":"12","key":"10.1016\/j.bbi.2023.05.005_b0135","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/mp.2016.3","article-title":"A meta-analysis of blood cytokine network alterations in psychiatric patients: Comparisons between schizophrenia, bipolar disorder and depression","volume":"21","author":"Goldsmith","year":"2016","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2023.05.005_b0140","doi-asserted-by":"crossref","DOI":"10.1038\/s41537-020-0098-4","article-title":"Inflammatory markers are associated with psychomotor slowing in patients with schizophrenia compared to healthy controls","volume":"6","author":"Goldsmith","year":"2020","journal-title":"NPJ Schizophr."},{"key":"10.1016\/j.bbi.2023.05.005_b0145","doi-asserted-by":"crossref","unstructured":"Haro, J. M., Kamath, S. A., Ochoa, S., Novick, D., Rele, K., Fargas, A., Rodr\u00edguez, M. J., Rele, R., Orta, J., Kharbeng, A., Araya, S., Gervin, M., Alonso, J., Mavreas, V., Lavrentzou, E., Liontos, N., Gregor, K., Jones, P. B., & SOHO Study Group. (2003). The Clinical Global Impression-Schizophrenia scale: A simple instrument to measure the diversity of symptoms present in schizophrenia. Acta Psychiatrica Scandinavica. Supplementum, 416, 16\u201323.","DOI":"10.1034\/j.1600-0447.107.s416.5.x"},{"issue":"10","key":"10.1016\/j.bbi.2023.05.005_b0150","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/mp.2015.206","article-title":"Conceptual convergence: Increased inflammation is associated with increased basal ganglia glutamate in patients with major depression","volume":"21","author":"Haroon","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2023.05.005_b0155","article-title":"Inflammation Effects on Brain Glutamate in Depression: Mechanistic Considerations and Treatment Implications","volume":"31","author":"Haroon","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"issue":"7","key":"10.1016\/j.bbi.2023.05.005_b0160","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/npp.2014.25","article-title":"IFN-alpha-induced cortical and subcortical glutamate changes assessed by magnetic resonance spectroscopy","volume":"39","author":"Haroon","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.bbi.2023.05.005_b0165","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/npp.2016.199","article-title":"Inflammation, Glutamate and Glia: A Trio of Trouble in Mood Disorders","volume":"42","author":"Haroon","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.bbi.2023.05.005_b0170","doi-asserted-by":"crossref","first-page":"7796","DOI":"10.3390\/ijms16047796","article-title":"Inflammatory biomarkers as differential predictors of antidepressant response","volume":"16","author":"Hashimoto","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbi.2023.05.005_b0175","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2147\/NDT.S218483","article-title":"The Role of Cytokines in Predicting the Efficacy of Acute Stage Treatment in Patients with Schizophrenia","volume":"16","author":"He","year":"2020","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.bbi.2023.05.005_b0180","first-page":"346","article-title":"Higher Levels of Pro-inflammatory Cytokines Are Associated With Higher Levels of Glutamate in the Anterior Cingulate Cortex in Depressed Adolescents","volume":"12","author":"Ho","year":"2021","journal-title":"Front. Psych."},{"issue":"43","key":"10.1016\/j.bbi.2023.05.005_b0185","doi-asserted-by":"crossref","first-page":"11496","DOI":"10.1523\/JNEUROSCI.2213-07.2007","article-title":"NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons","volume":"27","author":"Homayoun","year":"2007","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.bbi.2023.05.005_b0190","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1176\/appi.ajp.2016.16050503","article-title":"Treatment resistant schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology","volume":"174","author":"Howes","year":"2017","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2023.05.005_b0195","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3371\/CSRP.HUMI.070516","article-title":"Meta-Analysis of Cytokine and Chemokine Genes in Schizophrenia","volume":"12","author":"Hudson","year":"2018","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"issue":"7","key":"10.1016\/j.bbi.2023.05.005_b0200","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.biopsych.2018.09.009","article-title":"Glutamatergic Neurometabolite Levels in Patients With Ultra-Treatment-Resistant Schizophrenia: A Cross-Sectional 3T Proton Magnetic Resonance Spectroscopy Study","volume":"85","author":"Iwata","year":"2019","journal-title":"Biol. Psychiatry"},{"issue":"OCT","key":"10.1016\/j.bbi.2023.05.005_b0205","article-title":"C-Reactive protein: Higher during acute psychotic episodes and related to cortical thickness in schizophrenia and healthy controls","volume":"9","author":"Jacomb","year":"2018","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.bbi.2023.05.005_b0210","doi-asserted-by":"crossref","first-page":"e96021","DOI":"10.1371\/journal.pone.0096021","article-title":"Relationship between interleukin-6 gene polymorphism and hippocampal volume in antipsychotic-na\u00efve schizophrenia: Evidence for differential susceptibility?","volume":"9","author":"Kalmady","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bbi.2023.05.005_b0215","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"7027","key":"10.1016\/j.bbi.2023.05.005_b0220","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/bmj.312.7027.345","article-title":"Compliance therapy in psychotic patients: Randomised controlled trial","volume":"312","author":"Kemp","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.bbi.2023.05.005_b0225","unstructured":"Kim, S. (2015). ppcor: Partial and Semi-Partial (Part) Correlation. https:\/\/cran.r-project.org\/package=ppcor."},{"key":"10.1016\/j.bbi.2023.05.005_b0230","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.bbi.2018.09.016","article-title":"Inflammation in individuals with schizophrenia \u2013 Implications for neurocognition and daily function","volume":"74","author":"Kogan","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2023.05.005_b0235","article-title":"The Role of Peripheral Inflammation in Clinical Outcome and Brain Imaging Abnormalities in Psychosis: A Systematic Review","volume":"12","author":"Kose","year":"2021","journal-title":"Front. Psych."},{"issue":"4","key":"10.1016\/j.bbi.2023.05.005_b0240","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/mrm.1910300405","article-title":"Development of the human brain: In vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy","volume":"30","author":"Kreis","year":"1993","journal-title":"Magn. Reson. Med."},{"issue":"1","key":"10.1016\/j.bbi.2023.05.005_b0245","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jagp.2016.09.009","article-title":"Inflammation in Schizophrenia: Cytokine Levels and Their Relationships to Demographic and Clinical Variables","volume":"25","author":"Lee","year":"2017","journal-title":"Am. J. Geriatric Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.bbi.2023.05.005_b0250","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.schres.2005.04.008","article-title":"What does the PANSS mean?","volume":"79","author":"Leucht","year":"2005","journal-title":"Schizophr. Res."},{"issue":"9","key":"10.1016\/j.bbi.2023.05.005_b0255","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1002\/hbm.25819","article-title":"The differential association between local neurotransmitter levels and whole-brain resting-state functional connectivity in two distinct cingulate cortex subregions","volume":"43","author":"Li","year":"2022","journal-title":"Hum. Brain Mapp."},{"issue":"1","key":"10.1016\/j.bbi.2023.05.005_b0260","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0920-9964(98)00034-6","article-title":"The inflammatory response system in treatment-resistant schizophrenia: Increased serum interleukin-6","volume":"32","author":"Lin","year":"1998","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.bbi.2023.05.005_b0265","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.tins.2008.02.005","article-title":"Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia","volume":"31","author":"Lisman","year":"2008","journal-title":"Trends Neurosci."},{"issue":"1","key":"10.1016\/j.bbi.2023.05.005_b0270","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/schbul\/sbr069","article-title":"Glutamate in Schizophrenia: A Focused Review and Meta-Analysis of 1H-MRS Studies","volume":"39","author":"Marsman","year":"2013","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.bbi.2023.05.005_b0275","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/npp.2014.218","article-title":"Regulation of Extrasynaptic Glutamate Levels as a Pathophysiological Mechanism in Disorders of Motivation and Addiction","volume":"40","author":"McCullumsmith","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.bbi.2023.05.005_bib457","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/schbul\/sbaa156","article-title":"Changes in Brain Glutamate on Switching to Clozapine in Treatment-Resistant Schizophrenia","volume":"47","author":"McQueen","year":"2021","journal-title":"Schizophrenia bulletin"},{"issue":"7","key":"10.1016\/j.bbi.2023.05.005_b0280","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/jamapsychiatry.2016.0442","article-title":"Nature of Glutamate Alterations in Schizophrenia: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies","volume":"73","author":"Merritt","year":"2016","journal-title":"JAMA Psychiat."},{"key":"10.1016\/j.bbi.2023.05.005_b0285","doi-asserted-by":"crossref","unstructured":"Merritt, K., Mccutcheon, R., Aleman, A., Ashley, S., Beck, K., Bloemen, O., Borgan, F., Boules, C., Bustillo, J., Coughlin, J., Demjaha, A., Dempster, K., & Do, K. (2022). Variability and Magnitude of Brain Glutamate Levels in Schizophrenia: A Meta And Mega-Analysis. https:\/\/doi.org\/10.21203\/RS.3.RS-2057436\/V1.","DOI":"10.21203\/rs.3.rs-2057436\/v1"},{"issue":"6","key":"10.1016\/j.bbi.2023.05.005_b0290","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1001\/jamapsychiatry.2021.0380","article-title":"Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level","volume":"78","author":"Merritt","year":"2021","journal-title":"JAMA Psychiat."},{"issue":"4","key":"10.1016\/j.bbi.2023.05.005_b0295","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.biopsych.2013.07.011","article-title":"Prenatal poly(i:C) exposure and other developmental immune activation models in rodent systems","volume":"75","author":"Meyer","year":"2014","journal-title":"Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.bbi.2023.05.005_b0300","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","article-title":"Meta-analysis of cytokine alterations in schizophrenia: Clinical status and antipsychotic effects","volume":"70","author":"Miller","year":"2011","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.bbi.2023.05.005_b0305","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/da.22084","article-title":"Cytokine targets in the brain: Impact on neurotransmitters and neurocircuits","volume":"30","author":"Miller","year":"2013","journal-title":"Depress. Anxiety"},{"issue":"1","key":"10.1016\/j.bbi.2023.05.005_b0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/npp.2016.229","article-title":"The Immunology of Behavior\u2014Exploring the Role of the Immune System in Brain Health and Illness","volume":"42","author":"Miller","year":"2016","journal-title":"Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/j.bbi.2023.05.005_b0315","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: From evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.bbi.2023.05.005_b0320","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1038\/npp.2015.17","article-title":"Sex differences in depressive and socioemotional responses to an inflammatory challenge: Implications for sex differences in depression","volume":"40","author":"Moieni","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"10.1016\/j.bbi.2023.05.005_b0325","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.4088\/JCP.10m06745","article-title":"Stress and inflammation reduce brain-derived neurotrophic factor expression in first-episode psychosis: A pathway to smaller hippocampal volume","volume":"72","author":"Mondelli","year":"2011","journal-title":"J. Clin. Psychiatry"},{"issue":"5","key":"10.1016\/j.bbi.2023.05.005_b0330","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/schbul\/sbv028","article-title":"Cortisol and inflammatory biomarkers predict poor treatment response in first episode psychosis","volume":"41","author":"Mondelli","year":"2015","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.bbi.2023.05.005_b0335","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/schbul\/sbv151","article-title":"Treatment-resistant schizophrenia patients show elevated anterior cingulate cortex glutamate compared to treatment-responsive","volume":"42","author":"Mouchlianitis","year":"2016","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.bbi.2023.05.005_b0340","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41380-021-01297-6","article-title":"Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies","volume":"27","author":"Nakahara","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2023.05.005_b0345","unstructured":"Neuwirth, E. (2014). RColorBrewer: ColorBrewer Palettes. https:\/\/cran.r-project.org\/package=RColorBrewer."},{"issue":"4","key":"10.1016\/j.bbi.2023.05.005_b0350","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00406-021-01237-z","article-title":"Increased peripheral inflammation in schizophrenia is associated with worse cognitive performance and related cortical thickness reductions","volume":"271","author":"North","year":"2021","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"6","key":"10.1016\/j.bbi.2023.05.005_b0355","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0022-3956(99)00029-1","article-title":"NMDA receptor hypofunction model of schizophrenia","volume":"33","author":"Olney","year":"1999","journal-title":"J. Psychiatr. Res."},{"issue":"5","key":"10.1016\/j.bbi.2023.05.005_b0360","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/schbul\/sby160","article-title":"A Meta-analysis of Immune Parameters, Variability, and Assessment of Modal Distribution in Psychosis and Test of the Immune Subgroup Hypothesis","volume":"45","author":"Pillinger","year":"2019","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2023.05.005_b0365","unstructured":"R Core Team. (2020). R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing. https:\/\/www.r-project.org\/."},{"issue":"9","key":"10.1016\/j.bbi.2023.05.005_b0370","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/ijnp\/pyy062","article-title":"Kinetics of Cytokine Levels during Antipsychotic Treatment in Schizophrenia: A Meta-Analysis","volume":"21","author":"Romeo","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2023.05.005_b0375","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"issue":"9","key":"10.1016\/j.bbi.2023.05.005_b0380","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.biopsych.2021.06.008","article-title":"Medial Prefrontal Cortex Glutamate Is Reduced in Schizophrenia and Moderated by Measurement Quality: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies","volume":"90","author":"Smucny","year":"2021","journal-title":"Biol. Psychiatry"},{"issue":"Pt 23","key":"10.1016\/j.bbi.2023.05.005_b0385","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.1113\/jphysiol.2011.216978","article-title":"Relationship between physiological measures of excitability and levels of glutamate and GABA in the human motor cortex","volume":"589","author":"Stagg","year":"2011","journal-title":"J. Physiol."},{"issue":"7","key":"10.1016\/j.bbi.2023.05.005_b0390","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3109\/15622975.2011.583941","article-title":"Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired bloodbrain barrier integrity","volume":"13","author":"Steiner","year":"2012","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2023.05.005_b0395","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.psyneuen.2013.12.005","article-title":"Increased serum interleukin-6 levels in early stages of psychosis: Associations with at-risk mental states and the severity of psychotic symptoms","volume":"41","author":"Stojanovic","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbi.2023.05.005_b0400","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.schres.2020.06.028","article-title":"A meta-analysis of ultra-high field glutamate, glutamine, GABA and glutathione 1HMRS in psychosis: Implications for studies of psychosis risk","volume":"226","author":"Sydnor","year":"2020","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.bbi.2023.05.005_b0405","first-page":"414","article-title":"Proton magnetic resonance spectroscopy changes after antipsychotic treatment","volume":"20","author":"Szulc","year":"2013","journal-title":"Curr. Med. Chem."},{"issue":"4","key":"10.1016\/j.bbi.2023.05.005_b0410","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/s41386-019-0589-z","article-title":"Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: A proton magnetic resonance spectroscopy study","volume":"45","author":"Tarumi","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"1\u20133","key":"10.1016\/j.bbi.2023.05.005_b0415","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.schres.2013.10.011","article-title":"Antipsychotics\u2019 effects on blood levels of cytokines in schizophrenia: A meta-analysis","volume":"151","author":"Tourjman","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2023.05.005_b0420","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbr.2015.07.026","article-title":"Peripheral proinflammatory markers associated with ketamine response in a preclinical model of antidepressant-resistance","volume":"293","author":"Walker","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbi.2023.05.005_b0425","unstructured":"Wei, T., & Simko, V. (2017). R package \u2018corrplot\u2019: Visualization of a Correlation Matrix. https:\/\/github.com\/taiyun\/corrplot."},{"key":"10.1016\/j.bbi.2023.05.005_b0430","doi-asserted-by":"crossref","unstructured":"Wickham, H. (2016). ggplot2: Elegant Graphics for Data Analysis. Springer-Verlag New York. https:\/\/ggplot2.tidyverse.org.","DOI":"10.1007\/978-3-319-24277-4_9"},{"key":"10.1016\/j.bbi.2023.05.005_b0435","doi-asserted-by":"crossref","first-page":"146463","DOI":"10.1016\/j.brainres.2019.146463","article-title":"Association of peripheral cytokine levels with cerebral structural abnormalities in schizophrenia","volume":"1724","author":"Wu","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.bbi.2023.05.005_b0440","article-title":"The effect of antipsychotics on glutamate levels in the anterior cingulate cortex and clinical response: A 1H-MRS study in first-episode psychosis patients","volume":"13","author":"Zahid","year":"2022","journal-title":"Front. Psych."},{"issue":"2\u20133","key":"10.1016\/j.bbi.2023.05.005_b0445","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000356536","article-title":"First-episode psychosis: An inflammatory state?","volume":"21","author":"Zajkowska","year":"2014","journal-title":"Neuroimmunomodulation"},{"issue":"12","key":"10.1016\/j.bbi.2023.05.005_b0450","first-page":"e982","article-title":"Cortical grey matter volume reduction in people with schizophrenia is associated with neuro-inflammation. Translational","volume":"6","author":"Zhang","year":"2016","journal-title":"Psychiatry"},{"issue":"7","key":"10.1016\/j.bbi.2023.05.005_b0455","doi-asserted-by":"crossref","first-page":"940","DOI":"10.4088\/JCP.v65n0710","article-title":"Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: Relationship to outcome in schizophrenia","volume":"65","author":"Zhang","year":"2004","journal-title":"J. Clin. Psychiatry"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088915912300123X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088915912300123X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T03:38:08Z","timestamp":1762313888000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088915912300123X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":93,"alternative-id":["S088915912300123X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2023.05.005","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association between peripheral inflammation, brain glutamate and antipsychotic response in Schizophrenia: Data from the STRATA collaboration","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2023.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}